Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy

Abstract γδ T cells are a unique subset of T lymphocytes, exhibiting features of both innate and adaptive immune cells and are involved with cancer immunosurveillance. They present an attractive alternative to conventional T cell‐based immunotherapy due, in large part, to their lack of major histoco...

Full description

Bibliographic Details
Main Authors: Isabella A Revesz, Paul Joyce, Lisa M Ebert, Clive A Prestidge
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Clinical & Translational Immunology
Subjects:
Online Access:https://doi.org/10.1002/cti2.1492